152 related articles for article (PubMed ID: 12381683)
1. Involvement of tissue kallikrein but not plasma kallikrein in the development of symptoms mediated by endogenous kinins in acute pancreatitis in rats.
Griesbacher T; Rainer I; Tiran B; Evans DM
Br J Pharmacol; 2002 Nov; 137(5):692-700. PubMed ID: 12381683
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation.
Griesbacher T; Rainer I; Tiran B; Fink E; Lembeck F; Peskar BA
Br J Pharmacol; 2003 May; 139(2):299-308. PubMed ID: 12770935
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein inhibitors limit kinin B(2) antagonist-induced progression of oedematous to haemorrhagic pancreatitis in rats.
Griesbacher T; Rainer I; Tiran B; Peskar BA
Br J Pharmacol; 2008 Nov; 155(6):865-74. PubMed ID: 18695645
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of kinin action and kinin generation compared to dexamethasone pretreatment with respect to vascular effects and pancreatic enzymes in experimental acute pancreatitis.
Griesbacher T; Rainer I; Evans DM
Immunopharmacology; 1999 Sep; 43(2-3):219-24. PubMed ID: 10596856
[TBL] [Abstract][Full Text] [Related]
5. Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140.
Griesbacher T; Tiran B; Lembeck F
Br J Pharmacol; 1993 Feb; 108(2):405-11. PubMed ID: 8448591
[TBL] [Abstract][Full Text] [Related]
6. The kallikrein-kinin system in operated and non-operated patients with acute pancreatitis.
Hiltunen J; Kaukinen S; Pessi T; Ylitalo P
Acta Chir Scand; 1985; 151(4):371-5. PubMed ID: 3849928
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin attenuates the development of acute pancreatitis in rat.
Dembinski A; Warzecha Z; Ceranowicz P; Tomaszewska R; Stachura J; Konturek SJ; Konturek PC
J Physiol Pharmacol; 2003 Dec; 54(4):561-73. PubMed ID: 14726611
[TBL] [Abstract][Full Text] [Related]
8. Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin.
Bläckberg M; Berling R; Ohlsson K
Pancreas; 1999 Nov; 19(4):325-34. PubMed ID: 10547191
[TBL] [Abstract][Full Text] [Related]
9. Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis.
Griesbacher T; Lembeck F
Br J Pharmacol; 1992 Oct; 107(2):356-60. PubMed ID: 1384910
[TBL] [Abstract][Full Text] [Related]
10. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system.
Marcondes S; Antunes E
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):33-44. PubMed ID: 15638742
[TBL] [Abstract][Full Text] [Related]
11. Attenuated kinin release from human neutrophil elastase-pretreated kininogens by tissue and plasma kallikreins.
Dulinski R; Suder P; Guevara-Lora I; Rapała-Kozik M; Potempa J; Silberring J; Imamura T; Travis J; Kozik A
Biol Chem; 2003 Jun; 384(6):929-37. PubMed ID: 12887060
[TBL] [Abstract][Full Text] [Related]
12. A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness.
Wolf WC; Evans DM; Chao L; Chao J
Am J Pathol; 2001 Nov; 159(5):1797-805. PubMed ID: 11696440
[TBL] [Abstract][Full Text] [Related]
13. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
14. Endotoxemia in newborn rats attenuates acute pancreatitis at adult age.
Jaworek J; Konturek SJ; Macko M; Kot M; Szklarczyk J; Leja-Szpak A; Nawrot-Porabka K; Stachura J; Tomaszewska R; Siwicki A; Pawlik WW
J Physiol Pharmacol; 2007 Mar; 58(1):131-47. PubMed ID: 17440232
[TBL] [Abstract][Full Text] [Related]
15. Kallikrein-kinin system in acute pancreatitis: potential of B(2)-bradykinin antagonists and kallikrein inhibitors.
Griesbacher T
Pharmacology; 2000 Apr; 60(3):113-20. PubMed ID: 10754447
[TBL] [Abstract][Full Text] [Related]
16. Effects of R-102444 and its active metabolite R-96544, selective 5-HT2A receptor antagonists, on experimental acute and chronic pancreatitis: Additional evidence for possible involvement of 5-HT2A receptors in the development of experimental pancreatitis.
Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Fukushige J; Tani Y; Asai F
Eur J Pharmacol; 2005 Oct; 521(1-3):156-63. PubMed ID: 16183055
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the proteolytic cascade systems by high dose corticosteroids.
Aasen AO; Ruud TE; Pillgram-Larsen J; Röise O; Stadaas J
Acta Chir Scand Suppl; 1985; 526():56-65. PubMed ID: 3911708
[TBL] [Abstract][Full Text] [Related]
18. Melatonin precursor; L-tryptophan protects the pancreas from development of acute pancreatitis through the central site of action.
Leja-Szpak A; Jaworek J; Tomaszewska R; Nawrot K; Bonior J; Kot M; Palonek M; Stachura J; Czupryna A; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):239-54. PubMed ID: 15082881
[TBL] [Abstract][Full Text] [Related]
19. Influence of adenosine receptors on the development of caerulein-induced acute pancreatitis.
Szczerbiński M; Celiński K; Słomka M; Kasztelan-Szczerbińska B; Cichoz-Lach H
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):245-56. PubMed ID: 12898930
[TBL] [Abstract][Full Text] [Related]
20. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
